⌘K

Home/Filings/4/0001304492-25-000039

4//SEC Filing

Ashe Gena L 4

Accession 0001304492-25-000039

CIK 0001304492other

View on SEC.gov Company Profile

Filed

May 21, 8:00 PM ET

Accepted

May 22, 3:19 PM ET

Size

5.8 KB

Accession

0001304492-25-000039

Insider Transaction Report

Form 4

Period: 2025-05-20

Anterix Inc.ATEX

Chief Legal Officer & Corp Sec

Transactions

Award
Stock Option (Right to Buy)
2025-05-20+53,491→ 53,491 total
Exercise: $34.96Exp: 2035-05-20→ Common Stock (53,491 underlying)

Footnotes (1)

[F1]The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.

Documents

1 file

4
wk-form4_1747941549.xmlPrimary
FORM 4

Issuer

Anterix Inc.

CIK 0001304492

Entity typeother

Related Parties

1

filerCIK 0001669943

Filing Metadata

Form type: 4
Filed: May 21, 8:00 PM ET
Accepted: May 22, 3:19 PM ET
Size: 5.8 KB

View on SEC.gov